News

Media contact:
Molly Bowen  

BJGMC-JHU CRS Hosts 400+ at Community Events for World TB Day 2024

Post Date: 
2024-03-27
People with a sign for World TB Day
BJGMC-JHU Clinical Research Site (CRS) in Pune hosted 400+ engaging panel discussions, interactive outreach programs, and impactful awareness campaigns for World TB Day 2024.

World AIDS Day 2023

Post Date: 
2023-12-14
Pune Team
For World AIDS Day, BJGMC CRS), Pune, hosted a discussion on six major HIV related studies.

Photo from the Union Conference 2023

Post Date: 
2023-11-21
CIDI team at a table
Check out the photo gallery from CIDI at the 2023 Union Conference on Lung Health.

CIDI at the Union 2023

Post Date: 
2023-11-09
Union 2023 Conference
CIDI was in Paris for The Union Conference on Lung Health 2023! Check out what CIDI faculty and Johns Hopkins India Partners spoke about at the sessions listed!

Suniti Solomon: India’s Preeminent HIV Researcher & Activist

Post Date: 
2023-05-31
Suniti Solomon
Dr. Suniti Solomon detected India’s first cases of HIV. She also founded YRG CARE & raised CIDI Co-director Dr. Sunil Solomon. Learn about her commitment to science & unwavering dedication to compassionate patient care.

India Research Partnership Commemorates World TB Day

Post Date: 
2023-04-14
Group Photo
World TB Day event in Pune includes a special street play, counseling sessions, and research and education discussions, aimed to engage the community in healthy approaches to TB treatment and prevention under this year’s World TB Day theme "Yes we can end TB."

Accelerating progress toward the end of AIDS in India

Post Date: 
2023-01-31
Accelerating progress toward the end of AIDS in India
The third largest HIV/AIDS epidemic in the world, more than 2.4 million people in India are living with HIV.

Accelerating progress toward the end of AIDS in India

Post Date: 
2023-01-31
Accelerating progress toward the end of AIDS in India
The third largest HIV/AIDS epidemic in the world, more than 2.4 million people in India are living with HIV.

Research in Action Awards 2022

Post Date: 
2022-11-14
Dr. Amita Gupta
TAG’s 2022 Research in Action Awards will honor activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C around the world. Check it out to see Amita Gupta, GKII Co-Chair, receive her award.

CIDI at the Union 2022

Post Date: 
2022-11-08
The Union Conference 2022
CIDI researchers and faculty will join the virtual Union Conference--check out our agenda!

CIDI Baltimore Launch Event

Post Date: 
2022-09-14
Group photo of CIDI staff
Did you miss CIDI’s Baltimore launch event? You can view the recorded proceedings!

Johns Hopkins Receives Award for Antimicrobial Resistance Detection and Infection Control Partnership in India

Post Date: 
2021-12-14
Johns Hopkins Receives Award for Antimicrobial Resistance Detection and Infection Control Partner
In a press release issued Tuesday, December 7, the U.S. Centers for Disease Control and Prevention (CDC) announced the launch of two global networks to address the rise of antimicrobial resistance and other healthcare threats.

Researchers Identify Biomarker that Heralds Poor Outcomes in TB Patients

Post Date: 
2021-11-09
Dr. Akshay Gupte and colleagues discovered that elevated IL-6 can predict poor treatment outcomes, showcasing a need for including IL-6 in clinical screenings.

Mentorship Award!

Post Date: 
2021-11-02
Gauri Dhumal and Neetal Nevrekar Receive PEER Grant Award
Gauri Dhumal and Neetal Nevrekar received the award from USAID’s Women in Science Mentoring Program for separate pilot projects that study better tuberculosis treatment methods. Nishi Suryavanshi is their mentor.

CURE ID Moves to Automated Data Collection in Light of COVID Pandemic

Post Date: 
2021-07-13
Dr. Matt Robinson
Drs. Matt Robinson is leading JHU efforts in this FDA program, and Robert Bollinger and Jane McKenzie-White helped launch it before COVID.

Innovation During Times of Change  |  2020 Annual Report

Post Date: 
2021-03-30
2020 Annual Report
2020 was a year like no other. Learn what CCGHE discovered in our Annual Report.

Research Update: TB Trials Conducted by JHU-India Team Will Shorten Drug-Susceptible TB Treatment for Children and Adults

Post Date: 
2020-12-07
Research Updated
Reporting from the virtual 51st Union Conference on Lung Health, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) announced promising findings from 2 TB trials

Super-spreading Events: Lessons from India on Containment of COVID-19, Co-Hosted by Johns Hopkins India Institute

Post Date: 
2020-11-09
Super-spreading Events
Join Dr. Jennifer Nuzzo for a conversation with Drs. Brian Wahl and Sanjay Mehendale on what we can learn from India about pandemic safety. Register now!

India's National Digital Health Mission and the Patient Data Revolution, Co-Hosted by the Johns Hopkins India Institute

Post Date: 
2020-10-07
Livestream
For decades, global health systems have been transitioning from paper to electronic health records to improve patient data accessibility, particularly to facilitate epidemiological study and preventive care.

NIH Awards Johns Hopkins Baltimore-Washington-India Trials Group $460,679 in Supplemental COVID-19 Funding

Post Date: 
2020-06-30
The supplement is leveraging existing HIV research infrastructure and personnel for DAIDS-sponsored COVID research

Pages

Pune: BJ Govt medical College to check efficacy of ultra-short TB preventive therapy on people with HIV

Post Date: 
2024-01-02
Source: 
Indian Express
Vidya Mave
The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune. “Evidence from this study will give insights into the adoption of...

Pune : HIV infected people will get TB treatment from six months to a month

Post Date: 
2023-12-16
Source: 
Pune Mirror
Team photo
Director Dr. Nishi Suryavanshi, said, “One to Three HP' trial will generate scientific evidence for ultra-short-term TB preventive regimens. This may improve the TB prevention guideline system and policy in India. In turn, this study will help expand medical research on TB-HIV.

NIH clinical trial of tuberculous meningitis drug regimen begins

Post Date: 
2023-12-07
Source: 
NIH
Tuberculosis bacteria
The Improved Management with Antimicrobial Agents Isoniazid Rifampicin Linezolid for TBM (IMAGINE-TBM) trial will compare a six-month regimen of four drugs with the nine-month, standard-of-care regimen for TBM.

Common antibiotic can prevent drug-resistant TB in exposed kids, says study. But is it safe?

Post Date: 
2023-11-20
Source: 
Indian Express
Vidya Mave with text quote
Two clinical trials show how Levofloxacin, given once daily to children over six months, prevented infection in five-year-olds exposed to MDR-TB by 56 per cent and in adolescents by 45 per cent.

New study aims for best strategy to find recurrent cases of Tuberculosis

Post Date: 
2023-09-15
Source: 
Indian Express
Counsellors visit patients ' homes
A novel trial is underway in Pune to provide evidence on how best to find people with recurrent Tuberculosis (TB) , so that they can be quickly linked to care.

Taking HIV Care Online

Post Date: 
2023-09-06
Source: 
Span Magazine
A sexual health manager at Safe Zindagi explains the HIV self-testing process to a client. (Photograph courtesy Safe Zindagi)
Safe Zindagi , an online portal funded by USAID and PEPFAR, provides HIV care and services to hard-to-reach populations in India.

Navigating Adolescence With HIV

Post Date: 
2023-09-06
Source: 
Span Magazine
USAID-supported Adolescent-Friendly Health Centers create a supportive youth-led community that can help HIV positive children navigate challenges. (Photograph courtesy ACCELERATE)
USAID, with support of PEPFAR , set up Adolescent-Friendly Health Centers through its flagship program, ACCELERATE, led by Johns Hopkins University School of Medicine, to support 10-17-year-old HIV positive adolescents with comprehensive health care and services.

Making HIV Care Accessible

Post Date: 
2023-09-06
Source: 
Span Magazine
TAAL (Treatment, Adherence, Advocacy and Literacy) was launched in 2006, as a peer-led community pharmacy to provide high-quality and affordable HIV diagnostics, treatment and peer counseling services to people living with HIV. In 2020, with support from USAID, TAAL transitioned from a community...

Turning the Tide for HIV-Affected Families

Post Date: 
2023-09-06
Source: 
Span Magazine
The orphans and vulnerable children program—which serves children and adolescents who are at risk of infection, live with HIV or with HIV-positive caregivers—provide peer-led and family-centric care. One such USAID project, ACCELERATE , implemented by John Hopkins University, works closely with...

Pune study shows ‘promising results’ in bid to prevent TB among those at most risk

Post Date: 
2023-08-01
Source: 
Indian Express
Woman showing a diagram to a patient
Interim results are “promising” and show that a short treatment regimen called “3HP” could pave the way in preventing TB.

How a Pune trial SHINEs light on shorter TB treatment for children

Post Date: 
2023-06-26
Source: 
The Indian Express
TB OPD at Sassoon hospital
Last year, based on SHINE research, the WHO strongly recommended shortening the TB treatment duration in non-severe paediatric TB cases from six-four months.

Paediatric TB: An Overview (India)

Post Date: 
2023-06-26
Source: 
Survivors Against TB
Paediatric TB: An Overview (India)
Video: Shedding Light on Pediatric TB in India

Research shows India can shorten tuberculosis treatment

Post Date: 
2023-06-13
Source: 
The Hindu
Vidya Mave and Aarti Kinikar with text
Recent studies have found that the length of time tuberculosis patients need to stay on their regimen can be reduced from six to four months.

Pride & Beyond: Addressing Health Equity for LGBTQIA+ People in India

Post Date: 
2023-06-08
Source: 
CIDI
Mitr Clinic team
On Wednesday, June 7th, CIDI celebrated Pride Month at the event "Pride & Beyond: Addressing Health Equity for LGBTQIA+ People in India."

250,000 patients to benefit from free access to short-course TB prevention treatment across seven countries

Post Date: 
2023-03-30
Source: 
Unitaid
Amita Gupta, MD, MHS
The patient courses will include the three-month 3HP regimen, and the even shorter 1HP, that is only taken for 28 days. This contribution is part of the Consortium’s ongoing efforts to end TB and improve global health outcomes.

BJ Government Medical College launches new study to assess TB, HIV, diabetes among pregnant women

Post Date: 
2023-03-23
Source: 
The Indian Express
Team photo
The launch of the study coincides with the World TB week. “Titled `PraGaTHi’, this study will explore how the changes in immunity due to pregnancy and GDM increase the risk of TB in pregnant and postpartum women.”

What next after shortened TB treatment fails in key trial?

Post Date: 
2023-03-13
Source: 
Spotlight
Vidya Mave
Dr. Vidya Mave discusses the pros and cons of shortened tuberculosis treatment with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ).

The Virus Hunters Trying to Prevent the Next Pandemic

Post Date: 
2022-08-04
Source: 
Time
Sunil Solomon
Sunil Solomon: “Each of us brings a different skill set... The coalition is focused on translating what all of us find for clinical relevance to make sure that whatever we are doing is tailored toward improving the public’s health.”

Monkeypox: ‘No plans yet to get vaccine,’ says health ministry

Post Date: 
2022-07-26
Source: 
The Hindustan Times
Amita Gupta headshot
Dr. Amita Gupta spoke to the Hindustan Times about the monkeypox outbreak. “Currently mass vaccination is not required. Instead, priority is recommended for contacts of cases..."

The paradox of antimicrobial resistance in India

Post Date: 
2022-06-15
Source: 
Fogarty International Center
Dr. Matt Robinson
Fogarty International Center: Dr. Matt Robinson: "So sometimes you provide treatment for the worst possible scenario,” like prescribing antibiotics before identifying the cause of illness.

Pages

Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds

Post Date: 
2023-04-12
A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this...

Clone of Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds

Post Date: 
2023-04-12
A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this...

Johns Hopkins Medicine-Led Consortium to Receive Up to $200 Million to Fight TB Globally

Post Date: 
2022-08-04
Chaisson headshot; USAID Awards Johns Hopkins Medicine, Partners, Up to $200 Million for Global TB R
To address the global burden of TB, an international collaboration led by Johns Hopkins Medicine has today been awarded up to $200 million in research funding over five years by USAID for the SMART4TB project.

Gupta Named Director of the Division of Infectious Diseases

Post Date: 
2022-01-24
Dr. Amita Gupta
Congratulation on this amazing achievement! Dr.. Amita Gupta will be our next director of the Division of Infectious Diseases effective immediately.

CDC Launches Two Global Networks, Awards $22 Million to Combat Antimicrobial Resistance and Infectious Diseases

Post Date: 
2021-12-07
Dr. Matt Robinson
Dr. Matt Robinson’s collaboration with Indian partners on this CDC-funded effort builds on years of work on antimicrobial resistance.

Research Story Tip: Grants, Management Roles Keep Johns Hopkins A Leader In Hiv/Aids Clinical Trial Research

Post Date: 
2020-12-08
Research Story Tip
Researchers at Johns Hopkins Medicine learned that they now have an enhanced opportunity to help move the world toward a day when that observance is rendered obsolete.

Johns Hopkins Researchers Publish COVID-19 ‘Prediction Model’

Post Date: 
2020-09-23
Johns Hopkins News New COVID study findings published in The Annals of Internal Medicine are highlighted

Research Story Tip: International Johns Hopkins Study Says Broad Measures Needed to Prevent TB Spread in India

Post Date: 
2020-08-06
Dr. Mandar Paradkar
Johns Hopkins News Release: News release highlights study findings published in PLOS One by Dr. Mandar Paradkar and colleagues.

Study Shows Mobile Health, Video Technology, Influence Behavior of Affected Populations

Post Date: 
2020-07-09
Dr. Nishi Suryavanshi
Johns Hopkins News Release: Dr. Suryavanshi discusses her study on mobile health and technology training for improving care among HIV+ pregnant and post-partum women and their babies

In Women with HIV, TB Preventive Therapy Poses Greater Risk in Pregnancy than Postpartum

Post Date: 
2019-10-02
NIH Press Release: NIH announces NEJM published findings from the TB APPRISE trial, led by Dr. Amita Gupta

NIH Launches Large TB Prevention Trial for People Exposed to Multidrug-Resistant TB

Post Date: 
2019-06-25
Tuberculosis bacteria
NIH Press Release : NIH announces a large international clinical trial to prevent multidrug-resistant TB in children, adolescents, and adults who live with someone who has MDR-TB. CCGHE's Dr. Amita Gupta is a protocol chair.

National Institutes of Health Awards emocha Mobile Health $1 Million for Multi-State Study

Post Date: 
2018-08-29
emocha-logo
Bob Bollinger: "It is critical for patients to take tuberculosis medication as prescribed, and research supports new adherence strategies. . . "

One-Month Tuberculosis Prophylaxis as Effective as Nine-Month Regimen for People Living with HIV

Post Date: 
2018-03-05
The Indo-JHU Clinical Research Partnership participated in this important study that could change TB prevention for people living with HIV.

Tip Sheet: Johns Hopkins Researchers Present at Annual CROI Meeting

Post Date: 
2018-03-01
Newswise — Amita Gupta, M.D., deputy director of the Johns Hopkins University Center for Clinical Global Health Education at the Johns Hopkins University School of Medicine, will present a multicounty study of preventive treatment for tuberculosis (TB) in HIV-infected pregnant and postpartum women—...

emocha Named to 2018 Top 10 Most Innovative Companies in Health by Fast Company

Post Date: 
2018-02-20
The Most Innovative Companies list recognizes pioneering companies across 36 categories, from health to artificial intelligence to wellness.

Mobile Health and Wellness Clinic Debuts in Pune for Clinical Research and Community-Based Care

Post Date: 
2016-07-25
The Maryland-based health care informatics company CTIS and its founders, Raj and Bharti Shah, have collaborated with the Johns Hopkins Center for Clinical Global Health Education and Byramjee Jeejeebhoy Government Medical College to equip and dispatch a custom-designed mobile health care...

Proactively treating HIV patients at risk for tuberculosis with multidrug TB therapy doesn’t save more lives

Post Date: 
2016-03-17
In what investigators say is a surprise finding, results of a new study appear to strongly affirm the effectiveness of prescribing the anti-tuberculosis drug isoniazid alone — in place of the standard four-drug regimen — to prevent TB and reduce death in people with advanced HIV/AIDS...